Cipla gets nod for divestment of its consumer healthcare business to WOS

10 Jul 2015 Evaluate

Cipla has received an approval for divestment of its consumer healthcare business to a wholly owned subsidiary (WOS) (proposed to be incorporated) on a going-concern basis by way of a slump sale for a consideration of Rs 10.5 crore. The board of directors at their meeting held on July 09, 2015 has approved for the same.

The aforesaid divestment would enable the company to participate in the attractive & growing over-the-counter (OTC) market. This business requires a specialized FMCG kind of focus. A separate subsidiary would enable the company to attract right talent and provide the focus and attention required for this business. The sale agreement is yet to be finalized. The transaction is expected to be completed in the third quarter of FY 2015-16, subject to receipt of necessary approvals.

The amount and percentage of the turnover contributed by the OTC division of the company, during the last financial year 2014-15 was Rs 34.88 crore or approximately 0.3% of the Total Income (Audited Consolidated) of the company for FY 2014-15. The net worth of OTC division of the company as on March 31, 2015 was Rs. 6.45 crore contributing 0.06% of the net worth of the company.


Cipla Share Price

1328.25 15.40 (1.17%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×